Background: Breast Cancer (BC) is molecularly diverse disease that has been sub-classified in four major subtypes; (a) luminal A [estrogen and/or progesterone positive and Her 2neu negative], (b) luminal B [estrogen and/or progesterone positive and Her 2 neu positive], (c) Basal [triple negative] and (d) Her 2 neu [estrogen and/or progesterone negative and Her 2 neu positive]. Luminal A and luminal B are less aggressive subtypes and are associated with better prognosis as compared to basal and Her 2 neu subtypes. We aimed to evaluate the pattern of breast cancer subtypes and response to treatment and outcomes in Saudi women.
No takes yet. Share an insight, caveat, or question.
Eyad Fawzi Al Saeed (2013) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: